directed against human liver specific lipoprotein in vitro. This observation induces further speculation that genetic immunoregulatory action might be involved in the pathogenetic mechanisms of chronic active hepatitis in vivo.
It has been well established that there is a high prevalence of the HLA determinants Al, B8, and Dw3 in patients with HB8Ag negative chronic active hepatitis (CAH) compared with healthy controls (Mackay and Morris, 1972; Galbraith et al., 1974; Page et al., 1975) . The loci of the major histocompatibility complex (in man known as HLA) are located on the chromosome close to genes that regulate certain immune responses or Ir-genes (Bach and van Rood, 1976a; Marx, 1976) . Altered cellmediated immunity, governed by genetic factors, may be important to the susceptibility for chronic active hepatitis (Mackay and Morris, 1972; Page et al., 1975) and it has been suggested that these associations of CAH with HLA determinants might be significant to the course of the disease , to its response to immunosuppressive treatment (Vogten et al., 1976) , and to prognosis (Opelz et al., 1977) .
In addition, it has recently been shown that peripheral blood mononuclear cells (PMC) of patients with chronic active hepatitis may be cytotoxic in vitro for autologous hepatocytes (Geubel et al., 1976) and for avian erythrocytes coated with liver specific protein (LSP) purified from human liver (Vogten et al., 1978) Received for publication 11 January 1979 pathogenesis of the disease (Cochrane et al., 1976) .
In the course of extensive studies of the cytotoxicity of peripheral mononuclear cells for LSPcoated target cells in vitro we decided to evaluate whether any relationship existed between the HLAdeterminants Al, B8, and Dw3 and the degree of cell-mediated cytotoxicity in patients with chronic active hepatitis and the purpose of this report is to present our findings.
Methods

PATIENTS
We studied 20 consecutive, Caucasian, HB8Ag negative patients (six male, 14 female, aged 19-56 years) with severe chronic active hepatitis diagnosed by previously established clinical, biochemical, and morphological criteria (Soloway et al., 1972) . Histological confirmation of the diagnosis in these patients was based on a liver biopsy showing chronic active hepatitis (witb or without cirrhosis), subacute hepatitis with multilobular necrosis, or subacute hepatitis with bridging. All patients were initially randomly assigned to standard treatment with prednisone alone or in combination with azathioprine . Some clinical data of the individual patients and the time of cytotoxicity testing in relation to duration of disease, medication, and disease activity are summarised in Table 1. TECHNIQUES HLA typing of 18 alleles from locus A and 16 alleles from locus B was performed with 120 welldefined antisera using microcytotoxicity techniques (Mittal et al., 1968) and the typing of the HLA-D locus was done by a semimicro mixed leucocyte 523 A. J. M. Vogten, R. G. Shorter, and G. Opelz culture method (Opelz et al., 1977) . Cell-mediated cytotoxicity was tested using peripheral mononuclear cells from the peripheral blood as the effector cells for 51Cr labelled pigeon erythrocytes coated with human liver specific protein as the targets, as reported elsewhere (Vogten et al., 1978 3.9-5S5 *The patient numbers refer to the same patients as Table 1. lackedallthree determinants wereessentially negative (2 ± 1 %). In the group of 60 healthy volunteers no significant cytotoxicity was found (1 1 ± 0-2%).
Discussion
The HLA determinants can be used to divide patients with chronic active hepatitis into one subgroup bearing one or more of the HLA determinants Al, B8, or Dw3 and another consisting of patients lacking these determinants. Previously, we have found an association between HLA-Dw3 and a poor response to treatment, and postulated a genetic influence on both susceptibility to chronic active hepatitis and response to treatment with immunosuppressive drugs (Opelz et al., 1977) . Our present data show that in vitro cytotoxicity of peripheral mononuclear cells against LSP-coated target cells was primarily found in the first of these subgroups of such patients. As this cytototoxicity measures immune reactivity directed against liver lipoprotein(s) (Vogten et al., 1978) we may conclude that, in our patients with chronic active hepatitis, the presence of certain HLA determinants was apparently associated with increased cytotoxicity of peripheral mononuclear cells for target cells coated with liver specific protein, although whether this association would be sustained in a much larger series of patients is at present unknown. However, it has been suggested by some authors (Meyer zum Buschenfelde and Hopf, 1974) that autoimmune reactions to liver specific protein may be important in the production of chronic liver cell injury and are related to piece-meal necrosis in the liver biopsy (Cochrane et al., 1978) .
To explain the high incidence of HLA determinants Al, B8, and Dw3 in series of patients with chronic active hepatitis several possible mechanisms have been proposed (Bach and van Rood, 1976b; Marx, 1976) 
